BFC Planning’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.38K Buy
+225
New +$5.4K ﹤0.01% 2837
2026
Q2
– Sell
-13
Closed -$272 – 3494
2026
Q1
$272 Hold
13
– – ﹤0.01% 2910
2025
Q4
$299 Hold
13
– – ﹤0.01% 2998
2025
Q3
$391 Buy
+13
New +$390 ﹤0.01% 2774

Other funds holding RARE

BFC Planning's RARE Position: Q3 2026 in Review

BFC Planning opened a new position in Ultragenyx Pharmaceutical (RARE) in Q3 2026: 225 shares worth $3.38K. The stake represents ﹤0.01% of the portfolio and ranks #2837 among its holdings. This is a return to the name: BFC Planning previously reported a position in RARE as recently as Q1 2026.

BFC Planning first reported a position in RARE in Q3 2025 and has held it in 4 quarters since. 183 funds tracked by Wall St. Rank hold RARE as of Q3 2026.

  • BFC Planning held 225 shares of Ultragenyx Pharmaceutical worth $3.38K as of Q3 2026.
  • Ultragenyx Pharmaceutical was a new BFC Planning position in Q3 2026.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2837 holding.
  • BFC Planning first reported a position in Ultragenyx Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • 183 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.